ao1c01786_si_001.pdf (736.1 kB)
Discovery of a Novel Non-Narcotic Analgesic Derived from the CL-20 Explosive: Synthesis, Pharmacology, and Target Identification of Thiowurtzine, a Potent Inhibitor of the Opioid Receptors and the Ion Channels
journal contribution
posted on 2021-05-31, 07:04 authored by Stephanie Aguero, Simon Megy, Valeria V. Eremina, Alexander I. Kalashnikov, Svetlana G. Krylova, Daria A. Kulagina, Ksenia A. Lopatina, Mailys Fournier, Tatyana N. Povetyeva, Alexander B. Vorozhtsov, Sergey V. Sysolyatin, Vadim V. Zhdanov, Raphael TerreuxThe number of candidate
molecules for new non-narcotic analgesics
is extremely limited. Here, we report the identification of thiowurtzine,
a new potent analgesic molecule with promising application in chronic
pain treatment. We describe the chemical synthesis of this unique
compound derived from the hexaazaisowurtzitane (CL-20) explosive molecule.
Then, we use animal experiments to assess its analgesic activity in vivo upon chemical, thermal, and mechanical exposures,
compared to the effect of several reference drugs. Finally, we investigate
the potential receptors of thiowurtzine in order to better understand
its complex mechanism of action. We use docking, molecular modeling,
and molecular dynamics simulations to identify and characterize the
potential targets of the drug and confirm the results of the animal
experiments. Our findings finally indicate that thiowurtzine may have
a complex mechanism of action by essentially targeting the mu opioid
receptor, the TRPA1 ion channel, and the Cav voltage-gated
calcium channel.
History
Usage metrics
Categories
Keywords
non-narcotic analgesicspain treatmentTRPA 1 ion channelIon Channelschemical synthesisuse dockingthiowurtzineTarget Identificationuse animal experimentsmechanismNovel Non-Narcotic Analgesic Derivedv voltage-gated calcium channelCL -20 Explosiveanimal experimentscandidate moleculesPotent Inhibitormu opioid receptorreference drugsOpioid Receptorsdynamics simulations